This test is most useful if any of these apply to you.
Most of the bacteria a stool panel reports are long-term residents of your gut. This one arrives mainly in your food. Latilactobacillus sakei, still widely written as Lactobacillus sakei, is a lactic acid bacterium that lives in fermented meats, vegetables, and dairy. It shows up in your stool largely because you ate it, though whether it also establishes itself for the longer term is genuinely unsettled.
That makes the result harder to read than it looks, and more interesting. A high number can mean you had kimchi last week. It can also mean something in your gut is favoring this particular organism, which is what research in Crohn's disease and obesity has picked up on.
The assay uses PCR. PCR copies one specific stretch of DNA over and over until there is enough of it to detect and count. Here it targets a signature region of the bacterium's 16S ribosomal RNA gene. That gene differs enough between bacterial species to work as a name tag.
PCR finds this organism when culture cannot. In the foundational work behind this method, standard culture plates designed to grow lactobacilli produced nothing from human stool even though the molecular profile clearly showed the species was there. The DNA survives the trip; the living cell often doesn't.
So a positive result tells you the organism's DNA is present in meaningful quantity. It does not tell you the bacterium is alive, growing, or colonizing your intestinal lining.
Nothing in your body makes this bacterium. It arrives in food. Fermented meats, fermented vegetables including kimchi and sauerkraut, and some dairy products all carry it, and it is also sold as a probiotic strain. Once swallowed, it travels the length of the digestive tract and is shed in stool, alive or broken apart.
How much of it takes up residence along the way is an open question. Some large genomic surveys describe food-origin lactobacilli as a small but persistent part of the gut community, and several strains of this species survive simulated stomach acid and stick to intestinal cells in the lab. Other work reads most of what is detected as material in transit. The transient-versus-resident question has not been settled.
Lactobacilli as a group make up a small share of the bacteria in human stool, typically under one to two percent and often well below that. This species in particular is uncommon, though genomic surveys have found it more frequently in people eating westernized diets than in non-westernized populations. A low or undetectable reading is unremarkable on its own.
One of the more striking findings in the literature comes from a single exploratory study. In a cross-sectional comparison of stool from people with inflammatory bowel disease against healthy controls, this species stood out as sharply enriched in active Crohn's disease and sharply reduced in ulcerative colitis. Two inflammatory bowel conditions, opposite directions.
That split is why researchers have floated it as a candidate marker that might help distinguish the two. It is a candidate, not a test in use. The work was cross-sectional, in a modest single-country cohort, with no follow-up and no reported diagnostic accuracy figures. No independent study has reproduced an enrichment of that size, and the wider literature backs the direction only loosely: the Lactobacillus group as a whole runs modestly higher in active Crohn's, on the order of 1.5-fold and measured at genus level, while lactobacilli generally decline in ulcerative colitis. Nobody has shown this species separates Crohn's from colitis well enough to act on.
In the same Crohn's samples, protective butyrate-producing bacteria were depleted, Faecalibacterium prausnitzii among them. That pattern matters more than the single species, and it has been replicated many times across independent cohorts. A bloom of an acid-tolerant food organism alongside a collapse in the bacteria that feed your colon lining reads as a gut that has become inhospitable to its usual tenants, not as an infection.
A study of 88 people with obesity and 64 normal-weight controls found this species both more common and more abundant in the obesity group. Its presence tracked with how much fat people ate and with higher levels of reactive oxygen molecules in the colon. Reactive oxygen molecules are unstable byproducts of metabolism that damage cells.
The mechanism the researchers found flips the obvious reading. The strain they isolated from these participants makes unusually large amounts of catalase. Catalase is the enzyme that breaks down hydrogen peroxide, and the strain ramps it up when the chemical stress around it rises. A high-fat diet raises that stress in the colon lining, which hands a survival advantage to bacteria that can tolerate it. The bacterium is thriving in the conditions, not creating them.
When the same group gave this organism to high-fat-fed mice for four weeks, body weight and baseline oxidative markers didn't move. That is the cleanest available argument against reading a high number as a cause of anything, though it is animal work rather than a human trial.
Three findings point in different directions: high in Crohn's disease and low in ulcerative colitis in one exploratory study, and high in obesity where the organism looks like a bystander. What reconciles them is that this isn't a good-number bad-number marker. It's a readout on your gut environment. The bacterium tolerates acid, tolerates chemical stress, and arrives in your food. It rises when your gut suits it and when your diet supplies it, and those are different explanations with different implications. The number tells you about conditions in your intestine, not about a pathogen taking hold.
Start with the biggest problem: this test has no validated reference range. No professional guideline defines a normal level, a high level, or a cutoff for any condition. You will get a number with nothing established to compare it against.
Then there is day-to-day noise. In healthy adults sampled on consecutive days, thirteen of the 25 most abundant bacterial genera varied by more than 30 percent between samples, even though overall diversity stayed steady. Other quantitative work puts the swing higher still for many genera. Capturing a real baseline for a specific organism takes several separate collections rather than one; three to five is a working rule of thumb, not a validated number. Stool consistency, gut transit time, and lab processing all add scatter.
With no reference range, your own history is the only comparison you have. A single number in isolation is close to uninterpretable. A pattern across several samples, with your diet noted alongside, is worth something.
The practical approach: collect a baseline during a stretch of ordinary eating, and write down what you ate in the three days before. If you want to know whether the signal is dietary, retest after a week or two without fermented foods or probiotics. If it drops, you have your answer. If it stays elevated while your diet is unchanged and other markers on the panel look disturbed, that's a different situation.
For ongoing tracking, retest at three to six months if you are changing your diet, and at least annually otherwise. Read this species as one line in a broader picture rather than a result on its own, because that is all the evidence currently supports.
An isolated high or low number, with no symptoms and no other abnormality on the panel, does not warrant action. Note it, note your diet, and retest.
What deserves attention is a combination. A high reading alongside depleted butyrate producers, low overall diversity, and symptoms like persistent diarrhea, abdominal pain, blood in stool, or unexplained weight loss is a pattern worth pursuing. The next step is not more microbiome testing. It is fecal calprotectin, which measures actual intestinal inflammation and is a validated clinical test with established cutoffs, plus a stool pathogen panel to rule out infection. Those two answer a question this one cannot.
If calprotectin comes back elevated or the symptoms persist, that is the point to bring in a gastroenterologist, who can decide whether endoscopy and biopsy are warranted. Do not let a microbiome result delay that workup. And do not let a normal-looking microbiome result reassure you out of it either, because this species has never been shown to rule anything out.
Evidence-backed interventions that affect your Lactobacillus Sakei level
Lactobacillus Sakei is best interpreted alongside these tests.